2019
DOI: 10.3389/fgene.2019.00707
|View full text |Cite
|
Sign up to set email alerts
|

Target Genes of Autism Risk Loci in Brain Frontal Cortex

Abstract: Autism spectrum disorder (ASD) is a complex neuropsychiatric disorder. A number of genetic risk loci have been identified for ASD from genome-wide association studies (GWAS); however, their target genes in relevant tissues and cell types remain to be investigated. The frontal cortex is a key region in the human brain for communication and cognitive function. To identify risk genes contributing to potential dysfunction in the frontal cortex of ASD patients, we took an in silico approach i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 61 publications
0
13
0
Order By: Relevance
“…Interestingly, ABCF1 has been suggested to be one of the putative therapeutic targets for escitalopram, an SSRI treatment used for both depressive symptoms and anxiety [ 36 ]. Altered methylation of ABCF1 has also been seen to be associated with autism in an in silico analysis multi-omics data analysis including frontal cortex samples [ 37 ]. Previous studies investigating the association between PND with anxiety symptoms and cord blood DNA methylation have not compared with PND alone compared with healthy controls [ 16 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, ABCF1 has been suggested to be one of the putative therapeutic targets for escitalopram, an SSRI treatment used for both depressive symptoms and anxiety [ 36 ]. Altered methylation of ABCF1 has also been seen to be associated with autism in an in silico analysis multi-omics data analysis including frontal cortex samples [ 37 ]. Previous studies investigating the association between PND with anxiety symptoms and cord blood DNA methylation have not compared with PND alone compared with healthy controls [ 16 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…In our studies, we did not examine the effect of a metal deficiency ( Grabrucker et al, 2017 ) or excess ( Amal et al, 2020b ) on the development of an autistic phenotype, but we did examine how the administration of toxins (VPA or THAL) that induced autism-like behavior influenced the distribution of metals in the rat brain. The subject of the study of this work were three regions of the brain: CC, HPC, and CE, because their developmental disorders are particularly strongly associated with ASD pathogenesis ( Varghese et al, 2017 ; Bruchhage et al, 2018 ; Sun et al, 2019 ). In previous studies, also done on the THAL- and/or VPA-induced rat models of autism we showed changes in the content of neuroactive amino acids in the hippocampus ( Zieminska et al, 2018 ), and then we did the metabolomic profiles of this area of the brain ( Toczylowska et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, recent studies have described a reduction of essential amino acid levels and sex-specific alterations in serum amino acid concentration profiles in children with autism spectrum disorder, and an increasing number of studies indicate that patients with ASD may have unique metabolic patterns with a variety of amino acid metabolism dysregulations [28,29]. Based on these observations, the analysis of chromosomes, focusing particularly on chromosome 15, could exploit the chromosome walking approach to discover differences in the amino acid composition of proteins codified by the reported ASD loci [30][31][32] and could reveal further critical regions. Although there are many influencing factors, the base composition is considered as the driving force in amino acid usage.…”
Section: Discussionmentioning
confidence: 99%